Center-Authored Papers

Filters: Author is Cutler, Corey  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Young Adult
Pidala J, Chai X, Kurland BF, Inamoto Y, Flowers MED, Palmer J, Khera N, Jagasia M, Cutler C, Arora M et al..  2013.  Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):784-91. Abstract
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
Pidala J, Kurland BF, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S et al..  2011.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.. Blood. 117(17):4651-7. Abstract
Pidala J, Kurland BF, Chai X, Vogelsang G, Weisdorf DJ, Pavletic S, Cutler C, Majhail N, Lee SJ.  2011.  Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.. Haematologica. 96(10):1528-35. Abstract
United States
Pidala J, Kurland BF, Chai X, Majhail N, Weisdorf DJ, Pavletic S, Cutler C, Jacobsohn D, Palmer J, Arai S et al..  2011.  Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.. Blood. 117(17):4651-7. Abstract
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract
Treatment Outcome
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.  2008.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(2):197-207. Abstract
Lee S, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L et al..  2011.  Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1114-20. Abstract
Transplantation, Homologous
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.  2008.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(2):197-207. Abstract
Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H et al..  2009.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.. JAMA : the journal of the American Medical Association. 301(22):2349-61. Abstract
Transplantation Conditioning
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
Therapeutic Equivalency
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
Tacrolimus
Cutler C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
Survival Rate
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract
Survival Analysis
Lindsley CR, Saber W, Mar BG, Redd R, Wang T, Haagenson MD, Grauman PV, Hu Z-H, Spellman SR, Lee SJ et al..  2017.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. The New England journal of medicine. 376(6):536-547. Abstract
Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H et al..  2009.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.. JAMA : the journal of the American Medical Association. 301(22):2349-61. Abstract
Saito AM, Cutler C, Zahrieh D, Soiffer RJ, Ho VT, Alyea EP, Koreth J, Antin JH, Lee SJ.  2008.  Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(2):197-207. Abstract
Stem Cell Transplantation
Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, Wadleigh M, DeAngelo DJ, Stone RM, Sakamaki H et al..  2009.  Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.. JAMA : the journal of the American Medical Association. 301(22):2349-61. Abstract
Splenic Rupture
Stiff PJ, Bensinger WI, Abidi MH, Gingrich R, Artz AS, Nademanee A, Hansen KS, Sobczak C, Cutler C, Bolwell B et al..  2009.  Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(7):827-34. Abstract
Spleen
Stiff PJ, Bensinger WI, Abidi MH, Gingrich R, Artz AS, Nademanee A, Hansen KS, Sobczak C, Cutler C, Bolwell B et al..  2009.  Clinical and ultrasonic evaluation of spleen size during peripheral blood progenitor cell mobilization by filgrastim: results of an open-label trial in normal donors.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(7):827-34. Abstract
Shared Resources
Storb R, Antin JH, Cutler C.  2010.  Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(1 Suppl):S18-27. Abstract
Arai S, Jagasia M, Storer BE, Chai X, Pidala J, Cutler C, Arora M, Weisdorf DJ, Flowers MED, Martin PJ et al..  2011.  Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.. Blood. 118(15):4242-4249. Abstract